b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30001834</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>10</Month>\n            <Day>26</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>10</Month>\n            <Day>26</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1095-6859</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>150</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>09</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Gynecologic oncology</Title>\n                <ISOAbbreviation>Gynecol. Oncol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>446-450</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0090-8258(18)31017-5</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ygyno.2018.07.004</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE">Treatment for advanced epithelial ovarian cancer (EOC) consists of debulking surgery and (neo)adjuvant platinum-based chemotherapy. The aim of this study was to evaluate whether the time from surgery to adjuvant chemotherapy (TTC) was associated with clinical outcome.</AbstractText>\n                <AbstractText Label="METHODS">We identified all Dutch patients who received optimal or complete debulking surgery for primary EOC (FIGO IIb-IV) between 2008 and 2015 from the Netherlands Cancer Registry. TTC was divided into three groups based on the interquartile range (IQR). Early (&lt;25%) and prolonged (&gt;75%) TTC were compared to intermediate TTC (25-75%). Logistic regression was used to identify factors associated with a prolonged TTC and multivariable Cox regression to evaluate the independent effect of treatment interval on overall survival (OS). Patients receiving primary debulking surgery (PDS) and patients receiving interval debulking surgery (IDS) were analyzed separately.</AbstractText>\n                <AbstractText Label="RESULTS">4097 patients were included, 1612 underwent PDS and 2485 IDS. Median TTC was 29\xe2\x80\xafdays (IQR 24-37). Age\xe2\x80\xaf\xe2\x89\xa5\xe2\x80\xaf65, complete debulking surgery, postoperative complications, and hospitalization \xe2\x89\xa510\xe2\x80\xafdays were independently associated with a longer TTC for both PDS and IDS. TTC in the longest quartile was associated with poor OS after both PDS (Hazard Rate (HR) 1.43, 95% CI 1.09-1.88) and NACT-IDS (HR 1.22 (1.02-1.47)) when compared to the intermediate TTC, but only in patients with no macroscopic residual disease after surgery.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">Our study provides evidence that delayed initiation of adjuvant chemotherapy is an independent prognostic factor for worse overall survival after complete (interval)debulking surgery. We advise to start adjuvant chemotherapy within five to six weeks after debulking surgery.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Timmermans</LastName>\n                    <ForeName>M</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands; Department of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht, the Netherlands. Electronic address: m.timmermans@iknl.nl.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>van der Aa</LastName>\n                    <ForeName>M A</ForeName>\n                    <Initials>MA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lalisang</LastName>\n                    <ForeName>R I</ForeName>\n                    <Initials>RI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>GROW - School for Oncology and Developmental Biology, Maastricht, the Netherlands; Department of Internal Medicine, Division Medical Oncology, Maastricht University Medical Centre, the Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Witteveen</LastName>\n                    <ForeName>P O</ForeName>\n                    <Initials>PO</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Van de Vijver</LastName>\n                    <ForeName>K K</ForeName>\n                    <Initials>KK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kruitwagen</LastName>\n                    <ForeName>R F</ForeName>\n                    <Initials>RF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht, the Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sonke</LastName>\n                    <ForeName>G S</ForeName>\n                    <Initials>GS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>09</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Gynecol Oncol</MedlineTA>\n            <NlmUniqueID>0365304</NlmUniqueID>\n            <ISSNLinking>0090-8258</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>BG3F62OND5</RegistryNumber>\n                <NameOfSubstance UI="D016190">Carboplatin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>P88XT4IS4D</RegistryNumber>\n                <NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016190" MajorTopicYN="N">Carboplatin</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D065426" MajorTopicYN="N">Cytoreduction Surgical Procedures</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005185" MajorTopicYN="N">Fallopian Tube Neoplasms</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017239" MajorTopicYN="N">Paclitaxel</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010534" MajorTopicYN="N">Peritoneal Neoplasms</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>\n                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Adjuvant chemotherapy</Keyword>\n            <Keyword MajorTopicYN="Y">Epithelial ovarian cancer</Keyword>\n            <Keyword MajorTopicYN="Y">Neoadjuvant chemotherapy</Keyword>\n            <Keyword MajorTopicYN="Y">Overall survival</Keyword>\n            <Keyword MajorTopicYN="Y">Primary debulking surgery</Keyword>\n            <Keyword MajorTopicYN="Y">Timing</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30001834</ArticleId>\n            <ArticleId IdType="pii">S0090-8258(18)31017-5</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.ygyno.2018.07.004</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'